Diagnostics & Research
The Diagnostics & Research industry has a total of 51 stocks, with a combined market cap of $753.32 billion, total revenue of $166.29 billion and a weighted average PE ratio of 50.96.
Market Cap
753.32B
Revenue
166.29B
Profits
14.78B
PE Ratio
50.96
Profit Margin
8.89%
Dividend Yield
0.19%
51 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 215.06B | 1.14% | 2,268,706 | 43.74B |
| 2 | DHR | Danaher Corporation | 148.29B | -0.35% | 3,027,753 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 56.57B | -0.74% | 408,436 | 4.17B |
| 4 | A | Agilent Technologies, Inc. | 41.60B | -0.51% | 1,026,689 | 6.79B |
| 5 | IQV | IQVIA Holdings Inc. | 35.84B | -0.19% | 1,159,961 | 15.90B |
| 6 | MTD | Mettler-Toledo International Inc. | 29.40B | -0.02% | 194,284 | 3.94B |
| 7 | NTRA | Natera, Inc. | 27.54B | 0.55% | 2,706,697 | 2.12B |
| 8 | WAT | Waters Corporation | 22.13B | 0.14% | 408,084 | 3.11B |
| 9 | LH | Labcorp Holdings Inc. | 20.95B | 2.47% | 1,189,124 | 13.77B |
| 10 | DGX | Quest Diagnostics Incorporated | 19.97B | 1.69% | 1,020,618 | 10.85B |
| 11 | ILMN | Illumina, Inc. | 18.63B | 0.65% | 1,125,800 | 4.29B |
| 12 | MEDP | Medpace Holdings, Inc. | 16.60B | -0.51% | 235,507 | 2.36B |
| 13 | EXAS | Exact Sciences Corporation | 12.54B | -1.55% | 3,002,972 | 3.08B |
| 14 | GH | Guardant Health, Inc. | 12.19B | 0.49% | 2,745,460 | 902.57M |
| 15 | ICLR | ICON Public Limited Company | 12.15B | -0.54% | 627,735 | 8.10B |
| 16 | RVTY | Revvity, Inc. | 10.29B | 1.41% | 1,241,932 | 2.81B |
| 17 | QGEN | Qiagen N.V. | 9.45B | 1.16% | 1,302,316 | 2.07B |
| 18 | CRL | Charles River Laboratories International, Inc. | 8.27B | -1.66% | 900,919 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 6.02B | -0.76% | 1,013,373 | 1.91B |
| 20 | BLLN | BillionToOne, Inc. | 4.47B | -8.18% | 461,531 | 209.03M |
| 21 | SHC | Sotera Health Company | 4.45B | -2.06% | 10,271,860 | 1.15B |
| 22 | WGS | GeneDx Holdings Corp. | 4.04B | 0.74% | 628,126 | 402.19M |
| 23 | VCYT | Veracyte, Inc. | 3.30B | 0.02% | 1,160,979 | 495.14M |
| 24 | GRAL | GRAIL, Inc. | 2.86B | -0.82% | 998,781 | 134.29M |
| 25 | TWST | Twist Bioscience Corporation | 1.83B | -1.18% | 1,205,627 | 362.27M |
| 26 | NEOG | Neogen Corporation | 1.39B | 7.02% | 3,243,189 | 886.89M |
| 27 | NEO | NeoGenomics, Inc. | 1.30B | -3.08% | 2,224,482 | 709.16M |
| 28 | OPK | OPKO Health, Inc. | 1.03B | -2.90% | 3,038,808 | 642.07M |
| 29 | CSTL | Castle Biosciences, Inc. | 964.39M | -1.52% | 375,398 | 343.53M |
| 30 | FLGT | Fulgent Genetics, Inc. | 814.85M | 18.15% | 810,340 | 315.55M |
| 31 | CDNA | CareDx, Inc | 803.38M | 4.06% | 1,435,003 | 358.00M |
| 32 | PSNL | Personalis, Inc. | 615.41M | -3.62% | 1,435,504 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 587.25M | -0.47% | 1,046,627 | 825.30M |
| 34 | MDXH | MDxHealth SA | 222.24M | -3.44% | 183,596 | 98.95M |
| 35 | XGN | Exagen Inc. | 210.35M | -7.90% | 683,808 | 63.60M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 178.59M | -4.00% | 79,916 | 4.26M |
| 37 | PRE | Prenetics Global Limited | 166.96M | -0.08% | 126,138 | 57.05M |
| 38 | BNR | Burning Rock Biotech Limited | 126.94M | -3.76% | 12,832 | 74.86M |
| 39 | FONR | FONAR Corporation | 92.56M | -0.47% | 14,436 | 104.35M |
| 40 | BDSX | Biodesix, Inc. | 60.29M | -0.77% | 52,048 | 80.17M |
| 41 | NOTV | Inotiv, Inc. | 39.85M | -0.85% | 284,081 | 505.30M |
| 42 | STRR | Star Equity Holdings, Inc. | 35.14M | -2.05% | 10,938 | 137.86M |
| 43 | PRPO | Precipio, Inc. | 32.39M | -1.33% | 4,412 | 21.24M |
| 44 | PRPH | ProPhase Labs, Inc. | 11.74M | 1.22% | 1,046,826 | 5.59M |
| 45 | CHEK | Check-Cap Ltd. | 9.71M | 37.19% | 458,355 | - |
| 46 | BIAF | bioAffinity Technologies, Inc. | 9.25M | 0.49% | 145,548 | 7.68M |
| 47 | ADVB | Advanced Biomed Inc. | 8.79M | -7.62% | 275,041 | - |
| 48 | MYNZ | Mainz Biomed N.V. | 7.09M | -3.68% | 82,335 | 659.94K |
| 49 | XWEL | XWELL, Inc. | 4.84M | -4.55% | 5,550 | 30.60M |
| 50 | NDRA | ENDRA Life Sciences Inc. | 3.93M | -11.44% | 99,681 | - |
| 51 | ISPC | iSpecimen Inc. | 3.53M | -0.02% | 214,214 | 5.91M |